ERBB2 and breast neoplasm: For practical purposes, these subtypes may be approximated using clinicopathological factors rather than gene expression array criteria, including luminal A (LA) and luminal B (LB) breast tumors, overexpression of human epidermal growth factor receptor 2 (HER2), and triple-negative breast cancer (TNBC) [1].